Sandoz Strikes €150m Deal On Antibiotics In Austria
Joint Investment With Austrian Government Strengthens European Manufacturing Against COVID Backdrop
Sandoz has announced joint plans with the Austrian government to invest over €150m in antibiotics manufacturing.
You may also be interested in...
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
In a busy second quarter for Teva, a COVID-19 slump acted as a correction to the related boost in demand seen in the first quarter of 2020.
ANI Pharmaceuticals has chosen its new president and CEO to replace interim chief Patrick Walsh who stepped in after the departure Arthur Przybyl earlier this year. Meanwhile, key personnel announcements have also been made by Teva and Mylan.